Agilent Technologies Life Sciences and Applied Markets — Goodwill increased by 0.1% to $1.58B in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from $1.58B to $1.58B. Over 3 years (FY 2021 to FY 2024), Life Sciences and Applied Markets — Goodwill shows relatively stable performance with a 1.3% CAGR.
A stable or increasing balance reflects historical acquisition activity, while a sudden decrease signals potential impairment charges due to underperformance.
This represents the carrying value of goodwill allocated to the Life Sciences and Applied Markets segment, resulting fro...
Common in companies that grow through M&A; peers will show varying levels based on their acquisition history.
a_segment_life_sciences_and_applied_markets_goodwill| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.45B | $1.45B | $1.74B | $1.74B | $1.74B | $1.73B | $1.74B | $1.76B | $1.75B | $1.75B | $1.58B | $1.58B | $1.58B | $1.58B | $1.58B |
| QoQ Change | — | -0.3% | +20.5% | -0.2% | -0.2% | -0.2% | +0.6% | +0.7% | -0.2% | +0.2% | -10.0% | +0.3% | -0.1% | +0.1% | +0.1% |
| YoY Change | — | — | — | — | +19.7% | +19.8% | +0.0% | +0.9% | +0.9% | +1.3% | -9.4% | -9.8% | -9.7% | -9.8% | +0.3% |